81
48
Growth Score 81 in past quarter
-8 pts
Heat Score 48 in past quarter
-30 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
814940
ActualEyes is a healthcare center that replaces corneal transplantation with innovative cell therapy and pharmaceutical treatment.
- Naoki Okumura: Director
- Iku Sugioka: CEO
About the Company
Last updated: March 15, 2021 ActualEyes has developed therapeutics and products for treating Fuchs' corneal endothelium dystrophy. The products developed are eyedrops, regenerative cell-therapy based products, and therapeutics such as AE001 (phase I) and AE002.